ArticleBMJ open2022

Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival.

Sofi Sennefelt Nyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.